Apelin Inhibits Insulin Secretion in Pancreatic β-Cells by Activation of PI3-Kinase-Phosphodiesterase 3B

REFERENCES

• Tatemoto K, Hosoya M, Habata Y, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251:471–476.
   PubMed Web of Science ®Google Scholar
• Falcão-Pires I, Leite-Moreira A. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 2005; 24:1263–1276.
   Google Scholar
• O'Dowd B, Heiber M, Chan A, A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136:355–360.
   PubMed Web of Science ®Google Scholar
• Carpéné C, Dray C, Attané C, Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63:359–373.
   PubMed Web of Science ®Google Scholar
• Fan X, Zhou N, Zhang X, Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ. Biochemistry 2003; 42:10163–10168.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Takayama K, Zou M, The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99:87–92.
   PubMed Web of Science ®Google Scholar
• Bełtowski J. Apelin and visfatin: unique “beneficial” adipokines upregulated in obesity?. Med Sci Monit 2006; 12:RA112–RA119.
   PubMed Web of Science ®Google Scholar
• Kleinz M, Davenport A. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005; 107:198–211.
   PubMed Web of Science ®Google Scholar
• Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006; 41:798–806.
   PubMed Web of Science ®Google Scholar
• Reaux-Le Goazigo A, Alvear-Perez R, Zizzari P, Epelbaum J, Bluet-Pajot M, Llorens-Cortes C. Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. Am J Physiol Endocrinol Metab 2007; 292:E7–15.
   Web of Science ®Google Scholar
• Lee D, George S, O'Dowd B. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 2006; 27:190–194.
   PubMed Web of Science ®Google Scholar
• Japp A, Newby D. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008; 75:1882–1892.
   PubMed Web of Science ®Google Scholar
• Medhurst A, Jennings C, Robbins M, Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84:1162–1172.
   PubMed Web of Science ®Google Scholar
• Zhong J, Yu X, Huang Y, Yung L, Lau C, Lin S. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 2007; 74:388–395.
   PubMed Web of Science ®Google Scholar
• Valle A, Hoggard N, Adams A, Roca P, Speakman J. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol 2008; 20:79–84.
   PubMed Web of Science ®Google Scholar
• Boucher J, Masri B, Daviaud D, Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146:1764–1771.
   PubMed Web of Science ®Google Scholar
• Castan-Laurell I, Vítkova M, Daviaud D, Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol 2008; 158:905–910.
   PubMed Web of Science ®Google Scholar
• Heinonen M, Purhonen A, Miettinen P, Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 2005; 130:7–13.
   PubMed Web of Science ®Google Scholar
• Sörhede Winzell M, Magnusson C, Ahrén B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005; 131:12–17.
   PubMedGoogle Scholar
• Walz H, Wierup N, Vikman J, Beta-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin. Cell Signal 2007; 19:1505–1513.
   PubMedGoogle Scholar
• Waddleton D, Wu W, Feng Y, Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol 2008; 76:884–893.
   PubMed Web of Science ®Google Scholar
• Cong L, Chen K, Li J, Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochem J 2007; 403:519–525.
   PubMedGoogle Scholar
• Yan C, Zhao A, Bentley J, Loughney K, Ferguson K, Beavo J. Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons. Proc Natl Acad Sci USA 1995; 92:9677–9681.
   Google Scholar
• Whitman M, Kaplan D, Schaffhausen B, Cantley L, Roberts T. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 1985; 315:239–242.
   PubMed Web of Science ®Google Scholar
• Fournier A, Achard J, Mazouz H, Could angiotensin II type I receptor antagonists have a superior beneficial effect than that of angiotensin II converting enzyme inhibitors with respect to the risk of cerebrovascular accident?. Arch Mal Coeur Vaiss 1999; 92:997–1000.
   PubMedGoogle Scholar
• Li L, Yang G, Li Q, Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006; 114:544–548.
   PubMed Web of Science ®Google Scholar
• Härndahl L, Jing X, Ivarsson R, Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin. J Biol Chem 2002; 277:37446–37455.
   PubMedGoogle Scholar